| Sep 2008 | 2007 | 2006 | 2005 | 2004 | 2002 | ||
|---|---|---|---|---|---|---|---|
| Total Revenues ($Mil): | 0.70 | 1.51 | 2.74 | 3.78 | 0.11 | 0.00 | |
| Depreciation & Amort ($Mil): | 17.44 | 17.44 | 2.10 | 1.70 | |||
| Operating Income ($Mil): | -34.35 | -67.30 | -62.17 | -58.50 | -44.04 | -16.71 | |
| Net Income ($Mil): | -52.81 | -81.48 | -64.69 | -61.65 | -43.53 | ||
| Earnings Per Share ($): | -1.07 | -1.85 | -1.72 | -1.61 | -1.74 | N/C | |
| Dividends ($): | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sep 2008 | 2007 | 2006 | 2005 | 2004 | 2002 | ||
|---|---|---|---|---|---|---|---|
| Current Assets ($Mil): | 23.79 | 62.60 | 59.21 | 71.89 | 41.19 | 82.09 | |
| Current Liabilities ($Mil): | 18.95 | 21.24 | 22.37 | 14.84 | 13.63 | 6.24 | |
| Long Term Debt ($Mil): | 0.00 | 0.00 | 0.00 | N/C | 7.85 | N/C | |
| Shares Outstanding (000): | 50030 | 48850 | 38710 | 37380 | 30320 | 23660 | 0 |
| Common Equity ($Mil): | -28.51 | 3.90 | -1.71 | 42.83 | 33.80 | 87.56 |
| Sep 2008 | 2007 | 2006 | 2005 | 2004 | 2002 | ||
|---|---|---|---|---|---|---|---|
| Profit Margin (%): | -7544.29 | -5396.03 | -2360.95 | -1630.95 | -39572.73 | 0.00 | 0.00 |
| Return on Equity (%): | 0.00 | -2089.23 | 3783.04 | -143.94 | -128.79 | -16.53 | 0.00 |
| Return on Assets (%): | -90 | -103.89 | -90.60 | -74.65 | -68.54 | -15.36 | 0.00 |
| P/E Ratio: | 0 | -16.29 | -15.40 | -11.24 | -6.79 | 0.00 | 0.00 |
| Price/Book: | 0 | 377.40 | -599.44 | 15.79 | 10.60 | 1.50 | NaN |
| Debt Equity: | 0.00 | 0.00 | 0.00 | 0.00 | 0.23 | 0.00 | 0.00 |
| Interest Coverage: | 0.00 | -406.40 | -502.62 | -159.10 | -188.26 | -143.70 | 0.00 |
| Book Value ($): | -0.57 | 0.08 | -0.04 | 1.15 | 1.11 | 3.70 | 0.00 |
| Price/Sales: | 46.26 | 35.02 | 374.10 | 178.89 | 3258.02 | NaN | NaN |
| Dividend Payout (%): | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |

| AMGEN INC. | +9.80 | 56.34 | |
| GILEAD SCIENCES | -3.90 | 45.22 | |
| CELGENE CORPORA | -10.10 | 57.57 | |
| STEMCELLS INC. | -61.50 | 1.13 | |
| BIOGEN IDEC INC | -30.40 | 43.80 |
